Maltezou 2008.
Study characteristics | |||
Patient sampling | Cross‐sectional study
Prospective design
Sample: unclear
Direct comparison of different RADTs: no
Direct comparison of several throat culture techniques: no
Person performing the throat sample: unclear Exclusion if recent antibiotics use before inclusion: yes (within the previous week) Clinical selection of patients: clinical score (Centor) Presenting signs and symptoms: clinical evidence of pharyngitis including one of the 4 Centor criteria (fever, tonsillar exudate, tender enlarged anterior cervical lymph nodes and absence of cough) Age range for inclusion: 2 to 14 years |
||
Patient characteristics and setting | Sample size: 432
Age (distribution): mean = 6.8 years (calculated from data in table 1) GAS prevalence according to culture (with 95% confidence interval): 27.3% (95% CI not reported) Country of study: Greece Sex (% of girls): 53.9% Clinical severity assessment: Centor score Clinical setting: mixed (office‐based and hospital outpatient clinic) Multi‐centre study |
||
Index tests | Throat swab: 2 different swabs (1 swab for culture, 1 swab for performing the RADT) Commercial name of the RADT: Link 2 Strep A Rapid Test (Becton Dickinson) Type of RADT: EIA |
||
Target condition and reference standard(s) | Throat culture medium: standard Atmosphere of incubation: not reported Duration of incubation: 48 hours GAS confirmation: bacitracin disk and latex test Number of plates inoculated: not reported Assessment of GAS antibody response: no Relevant details: ‐ | ||
Flow and timing | No follow‐up | ||
Comparative | |||
Type of study | Journal article | ||
Notes | Funded by the Hellenic Center for Disease Control and Prevention | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was it a cross‐sectional study or a RCT? | Yes | ||
Were selection criteria clearly described (at least presenting signs and symptoms and age limits for inclusion)? | Yes | ||
Was clinical selection of patients avoided? | No | ||
Were patients seen in an ambulatory care setting? | Yes | ||
Unclear | High | ||
DOMAIN 2: Index Test All tests | |||
Were the RADT results interpreted with blinding of the results of culture? | Yes | ||
Was the type of the RADT mentioned (EIA or OIA)? | Yes | ||
Were RADTs conducted during consultation time? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Were culture results interpreted with blinding of the results of the RADT? | Unclear | ||
Is the throat culture method likely to correctly identify GAS (laboratory culture on a blood agar plate during 48 hr)? | Yes | ||
Were the culture medium, atmosphere, duration of incubation and GAS‐confirmation technique described? | No | ||
High | High | ||
DOMAIN 4: Flow and Timing | |||
Was the delay between the performance of the RADT and throat culture plating less than 48 hours? | Yes | ||
Did all patients receive a throat culture? | Yes | ||
Did patients receive the same throat culture method? | Yes | ||
Were undetermined/uninterpretable results reported? | No | ||
Were withdrawals from the study explained? | Yes | ||
Low |